What Is Berberine and What Does It Do? Trials, Doses and Cautions

A woman in a navy linen shirt reads a leaflet beside a plain box in a bright kitchen, with a yellow jug and a bowl of green apples on the counter
In this article
  1. What is berberine, and which plants contain it?
  2. What does berberine do in the body?
  3. Does berberine lower blood sugar? The trials in UK units
  4. Does berberine help with weight, and why is it compared with the injections?
  5. Berberine, cholesterol and blood pressure: what the trials found
  6. Why are doctors cautious about berberine?
  7. What is a "berberine complex"?
  8. Does berberine work, and how would you know?
  9. Before you start berberine: the cautions
  10. What we don't know
  11. Frequently asked questions

Berberine is a bitter, yellow alkaloid from the roots and bark of Indian barberry (Berberis aristata), goldenseal, Oregon grape and Chinese goldthread, traditional in Chinese and Ayurvedic medicine and now used for blood sugar, cholesterol and weight. In pooled trials, mostly at 900 to 2,400 mg a day and almost all in people with type 2 diabetes or raised cholesterol, berberine lowered HbA1c by about 0.6 percentage points (about 7 mmol/mol), fasting glucose by about 0.8 mmol/L and LDL cholesterol by about 0.46 mmol/L over roughly three months, and body weight by about 0.9 to 2 kg.10, 11, 12, 13 What it does outside diabetes is the open question: the trials there are in raised cholesterol, PCOS (now called PMOS by the NHS) and bowel polyps, one ran two years at 600 mg a day,11, 24 and it is not a medicine: the UK has no licensed berberine product, the NHS website no page on it, and the GB register no authorised claim for it. It interacts with common medicines and is avoided in pregnancy and breastfeeding.

Sources checked on 30 October 2026.

  • What it is: a plant alkaloid from roots and bark; not turmeric and not a vitamin
  • What the trials found: HbA1c about −0.6 points, LDL about −0.46 mmol/L, weight about −0.9 to −2 kg, mostly in type 2 diabetes or raised cholesterol at 900 to 2,400 mg a day
  • What to check first: your medicines with a pharmacist; never in pregnancy, breastfeeding or childhood

What is berberine, and which plants contain it?

Berberine is an isoquinoline alkaloid, so intensely yellow it was once used as a dye. It accumulates in the roots, rhizomes and stem bark of plants in the barberry family and a few relatives: Indian barberry (Berberis aristata, daruharidra in Ayurveda), common barberry (Berberis vulgaris), goldenseal (Hydrastis canadensis), Oregon grape and Chinese goldthread (Coptis chinensis).1 The supplement is the purified alkaloid, usually as berberine hydrochloride, extracted from these roots or barks.

What does berberine do in the body?

Several things at once. In gut cells it triggers release of the hormone GLP-1 through bitter-taste receptors, which is where the comparison with the weight-loss injections comes from.3 Much of its action may be in the gut rather than the blood: in the 409-person PREMOTE trial the glucose effect tracked a change in how gut bacteria handled bile acids.4 Very little swallowed berberine reaches the bloodstream, under 1% in animal studies, because it is poorly absorbed, pumped back into the gut and metabolised in the gut wall and liver.2 Dihydroberberine, a reduced form, gave several-fold higher blood levels in a supplier-funded pilot of five men whose glucose did not differ; no trial has tested weight or cholesterol.5 When you start, the gut reacts first, with looser or firmer stools and wind, described as transient in one pilot.6

Does berberine lower blood sugar? The trials in UK units

In people with type 2 diabetes, yes, modestly and fairly consistently. Every trial below was in diagnosed diabetes or raised cholesterol, nearly all in China, mostly at 900 mg a day or more in divided doses, for two weeks to six months; HbA1c is in percentage points with the NHS mmol/mol in brackets.4, 6-11

Trial or review People Dose and duration What changed
Yin 2008 pilot, vs metformin (study A) and added to existing treatment (study B)6 36 newly diagnosed; 48 poorly controlled 500 mg three times a day, 3 months A: HbA1c 9.5% (80 mmol/mol) to 7.5% (58), fasting glucose 10.6 to 6.9 mmol/L, "similar" to metformin, no placebo group. B: HbA1c 8.1% (65) to 7.3% (56)
Zhang 2008, vs placebo7 116 with type 2 diabetes and raised lipids 1,000 mg a day, 3 months HbA1c 7.5% (58) to 6.6% (49); fasting glucose 7.0 to 5.6 mmol/L; total cholesterol 5.31 to 4.35 mmol/L
PREMOTE 2020, vs placebo4 409 newly diagnosed, 20 centres 600 mg twice daily, alone or with live cultures, 12 weeks HbA1c −0.99 points (about −11 mmol/mol) vs −0.59 (about −6) on placebo; more gut side effects
Liang 2019, 28 trials8 2,313 with type 2 diabetes Doses varied, some above 2 g a day Fasting glucose −0.54 mmol/L; HbA1c about −0.5 points; the glucose effect was no longer significant in trials longer than 90 days
Guo 2021, 46 trials9 4,158 with type 2 diabetes, alone or added to treatment Usually 600 to 1,500 mg a day, 4 weeks to 6 months HbA1c −0.73 points (about −8 mmol/mol); fasting glucose −0.86 mmol/L; LDL −0.86 mmol/L; BMI −1.07
Xie 2022, 37 trials10 3,048 with type 2 diabetes Mostly 900 to 2,400 mg a day, 2 weeks to 6 months Fasting glucose −0.82 mmol/L; HbA1c −0.63 points (about −7 mmol/mol); no increase in hypoglycaemia or adverse events
Blais 2023, 18 trials11 1,788 with raised cholesterol 900 to 1,500 mg a day, 4 to 24 weeks LDL −0.46 mmol/L; total cholesterol −0.48; triglycerides −0.34; gut side effects 2 to 23% vs 2 to 15%

The effect scaled with the starting glucose level, so the pooled trials saw no extra hypoglycaemia.10 In type 2 diabetes the one head-to-head with metformin is a 36-person pilot with no placebo arm; berberine vs metformin goes through it and the PCOS trials, and nobody should swap a prescribed medicine on their strength. And prediabetes has one 12-week pilot of 34 people, which favoured berberine but is too small to answer "will it help my pre-diabetes?"; the NHS Diabetes Prevention Programme does, and a GP can refer you.25, 21

Does berberine help with weight, and why is it compared with the injections?

Across 23 randomised trials in adults, berberine reduced body weight by about 0.9 kg; the most favourable pooling of 12 trials found about 2 kg, and three poolings found the waist 1 to 3 cm smaller, mostly in people with metabolic conditions.12, 13, 22 In the 68-week STEP 1 trial, the injectable GLP-1 medicine semaglutide reduced body weight by 14.9% against 2.4% on placebo.14 Both are real and not in the same league; the nickname that makes berberine sound like the injections in a capsule is a myth. Does berberine work for weight loss sets out the trials and the comparison, and berberine with or after the weight-loss injection answers the question UK forums ask most.

Berberine, cholesterol and blood pressure: what the trials found

In 18 placebo-controlled trials of 1,788 adults with raised cholesterol, berberine at 900 to 1,500 mg a day lowered LDL cholesterol by 0.46 mmol/L, total cholesterol by 0.48 mmol/L and triglycerides by 0.34 mmol/L over 4 to 24 weeks, and raised HDL by 0.06 mmol/L (0.11 in women), and that is not a statin substitute: statins lower LDL by more and have decades of trials measuring heart attacks and strokes, which berberine lacks.11, 18 Berberine's lipid mechanism differs from a statin's; a seven-day study in 60 healthy adults found no meaningful interaction between berberine and simvastatin or fenofibrate, but two weeks of berberine reduces the activity of CYP3A4, the liver enzyme that clears several statins, so anyone on a statin tells their pharmacist before adding it.15, 16 What medicines interact with berberine has the statin row and the rest. Blood pressure is thinner ground: the 2025 pooling of placebo-controlled trials in metabolic syndrome found no effect, and a 2021 review called the evidence low quality and inconclusive; berberine is not a blood-pressure treatment.22, 23

Why are doctors cautious about berberine?

No berberine medicine is licensed, so nobody has set a dose, checked manufacturing or written a safety leaflet. The NHS website has no page on it and the GB register has no authorised claim for it, so it cannot lawfully be sold as doing anything for blood sugar.19 The glucose trials are short, mostly from one country and almost all in diagnosed type 2 diabetes, so the result in anyone else is unknown, and products vary in what they contain. And berberine's interactions with other medicines are documented: it raised blood levels of the transplant medicine ciclosporin by about 29%, and two weeks at 900 mg a day reduced the activity of three enzymes (CYP3A4, CYP2D6, CYP2C9) that clear many antidepressants, blood-pressure tablets, anticoagulants and statins.16, 17 A 2026 review put it plainly: in people on several medicines it should be managed as an active drug, not an inert supplement.2

What is a "berberine complex"?

A capsule pairing berberine with minerals that carry authorised wording, usually chromium and zinc. The GB register allows two sentences about chromium, "chromium contributes to normal macronutrient metabolism" and "chromium contributes to the maintenance of normal blood glucose levels", for any food supplying at least 15% of the 40 µg reference intake, and zinc "contributes to normal carbohydrate metabolism"; berberine has no authorised claim, so the compliant sentences on a label belong to the minerals.19 A UK complex typically supplies a few hundred milligrams of berberine hydrochloride a day, often from Indian barberry extract, with chromium and zinc at a stated share of the reference intake; the trials above mostly used 900 to 2,400 mg a day in divided doses with meals.10 What chromium does for blood sugar explains the register wording and the trials. For dose, timing and forms see how to take berberine; do berberine patches work explains why skin delivery has no trial.

Does berberine work, and how would you know?

Change one thing. The forum pattern is to start berberine, a low-carb diet and a fasting window in the same week, see HbA1c fall and credit the capsule; nobody can tell what did it. If you have type 2 diabetes, note your last HbA1c, agree the plan with your diabetes team (berberine adds to the glucose-lowering of insulin and gliclazide), take the product as the label says with meals for 12 weeks, change nothing else, and have HbA1c measured again; the trials saw their effect inside three months and one pooled analysis found it was no longer significant beyond 90 days, so 12 weeks is long enough and the point to review.8 If you use a meter, record fasting and two-hour post-meal readings for a week before you start and in week 12. If you do not have diabetes, no trial tells you what to expect; whether the glucose "spikes" continuous monitors show in healthy people matter is answered in the apple cider vinegar evidence page.

Before you start berberine: the cautions

Berberine displaces bilirubin from its carrier protein, which is why it is avoided in pregnancy, breastfeeding and infancy: in a jaundiced newborn the freed bilirubin can damage the brain;20 the French food-safety agency's 2019 opinion also advises children, adolescents and people with diabetes or liver or heart conditions not to take berberine supplements.26 Anyone trying to conceive stops it before they might be pregnant. Caution also applies with ciclosporin (blood levels rise), anticoagulants, glucose-lowering medicines (additive effect) and statins (CYP3A4): tell your pharmacist what you take.16, 17 Berberine side effects and who should avoid it covers gut effects, hypos, the liver question, G6PD deficiency and mood reports. Berberine for PCOS sets out the trials.

What we don't know

Whether berberine changes glucose in people without diabetes; whether its glucose effects last beyond six months; what a 350 mg daily dose does, since the glucose trials mostly used 900 mg or more; whether dihydroberberine's higher blood levels change any outcome; and what more than two years of use does. Neighbouring pages: apple cider vinegar gummies, NMN, resveratrol, astaxanthin and glutathione.

Frequently asked questions

Is berberine just turmeric?

No. Turmeric is the rhizome of Curcuma longa and its active pigment is curcumin; berberine is an alkaloid from the roots and bark of barberry, goldenseal and goldthread. They share a yellow colour and nothing else.1

Which foods are rich in berberine?

None in any useful amount. Berberine sits in roots and bark, not in fruit, leaves or anything on a plate. Every trial used an extract.1

Does berberine do anything if you do not have diabetes?

In raised cholesterol, 18 trials found LDL about 0.46 mmol/L lower; for blood sugar there is one 34-person prediabetes pilot and a five-man absorption study in which glucose did not change.11, 25, 5

What do the NHS and the Mayo Clinic say about berberine?

No NHS page, no licensed medicine, and sale as a food supplement under general food law, so no regulator has set a dose or approved a use.19 The Mayo Clinic is an American hospital, not a UK regulator, and nothing it publishes changes the UK position.

Sources

  1. Rad SZK, Rameshrad M, Hosseinzadeh H. Toxicology effects of Berberis vulgaris (barberry) and its active constituent, berberine. Iranian Journal of Basic Medical Sciences, 2017. Narrative review; funding not stated on PubMed. PubMed 28656087.
  2. Dumitru CN, et al. Berberine-drug interactions: mechanisms, clinical relevance and risk stratification. Pharmaceuticals, 2026. Narrative review; no conflicts declared. PubMed 42653808.
  3. Yu Y, et al. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways. Biochemical Pharmacology, 2015. Cell study; funding not stated on PubMed. PubMed 26206195.
  4. Zhang Y, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nature Communications, 2020. Randomised trial, 409 newly diagnosed adults, 20 centres, 12 weeks; government-funded, no competing interests. PubMed 33024120.
  5. Moon JM, et al. Absorption kinetics of berberine and dihydroberberine and their impact on glycemia: a randomized, controlled, crossover pilot trial. Nutrients, 2021. Crossover pilot, 5 men; supplier-funded. PubMed 35010998.
  6. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 2008. Pilot trials, 36 and 48 adults with type 2 diabetes, 3 months; hospital and US public funding. PubMed 18442638.
  7. Zhang Y, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Journal of Clinical Endocrinology and Metabolism, 2008. Randomised trial, 116 adults with type 2 diabetes, 1,000 mg a day for 3 months; funding not stated on PubMed. PubMed 18397984.
  8. Liang Y, et al. Effects of berberine on blood glucose in patients with type 2 diabetes mellitus. Endocrine Journal, 2019. Meta-analysis, 28 randomised trials, 2,313 adults with type 2 diabetes; funding not stated on PubMed. PubMed 30393248.
  9. Guo J, et al. The effect of berberine on metabolic profiles in type 2 diabetic patients. Oxidative Medicine and Cellular Longevity, 2021. Meta-analysis, 46 randomised trials, 4,158 adults with type 2 diabetes; no conflicts declared. PubMed 34956436.
  10. Xie W, et al. Glucose-lowering effect of berberine on type 2 diabetes. Frontiers in Pharmacology, 2022. Meta-analysis, 37 randomised trials, 3,048 adults with type 2 diabetes; no conflicts declared. PubMed 36467075.
  11. Blais JE, Huang X, Zhao JV. Overall and sex-specific effect of berberine for the treatment of dyslipidemia in adults. Drugs, 2023. Meta-analysis, 18 randomised trials, 1,788 adults with raised cholesterol; funding not stated on PubMed. PubMed 36941490.
  12. Elahi Vahed I, et al. The effect of berberine on obesity indices. International Journal of Obesity, 2026. Meta-analysis, 23 randomised trials in adults; no conflicts declared. PubMed 41310257.
  13. Asbaghi O, et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes. Clinical Nutrition ESPEN, 2020. Meta-analysis, 12 randomised trials; no conflicts declared. PubMed 32690176.
  14. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 2021. Randomised trial, 1,961 adults with obesity, 68 weeks; manufacturer-funded. PubMed 33567185.
  15. Li G, et al. Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate. Drug Design, Development and Therapy, 2019. Randomised open-label study, 60 healthy adults, 7 days; no conflicts declared. PubMed 30587933.
  16. Guo Y, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. European Journal of Clinical Pharmacology, 2012. Crossover study in healthy men, 2 weeks; no conflicts declared. PubMed 21870106.
  17. Wu X, et al. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients. European Journal of Clinical Pharmacology, 2005. Controlled trial, 104 kidney-transplant recipients, 3 months; funding not stated on PubMed. PubMed 16133554.
  18. NHS. Statins. nhs.uk/medicines/statins. Page last reviewed 5 May 2026. Read 30 October 2026.
  19. Department of Health and Social Care. Great Britain nutrition and health claims (NHC) register. gov.uk. Page last updated 19 May 2026. Read 30 October 2026.
  20. Chan E. Displacement of bilirubin from albumin by berberine. Biology of the Neonate, 1993. Laboratory and rat study. PubMed 8513024.
  21. NHS England. NHS Diabetes Prevention Programme. england.nhs.uk/diabetes/diabetes-prevention.
  22. Liu D, et al. Efficacy and safety of berberine on the components of metabolic syndrome. Frontiers in Pharmacology, 2025. Meta-analysis of placebo-controlled trials in metabolic syndrome; no conflicts declared. PubMed 40740996.
  23. Suadoni MT, Atherton I. Berberine for the treatment of hypertension. Complementary Therapies in Clinical Practice, 2021. Systematic review, 7 trials, 614 people; funding not stated on PubMed. PubMed 33461163.
  24. Chen YX, et al. Lancet Gastroenterology and Hepatology, 2020. Randomised trial, 1,108 adults, up to 2 years; government-funded. PubMed 31926918.
  25. Panigrahi A, Mohanty S. BMC Endocrine Disorders, 2023. Randomised pilot, 34 adults, 12 weeks; no conflicts declared. PubMed 37679692.
  26. ANSES. Opinion on the safety of berberine-containing plants in food supplements, saisine 2018-SA-0095. Agency opinion, in French, 1 August 2019. anses.fr.

Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.

This article is general information, not medical advice. Berberine interacts with prescription medicines and is not taken in pregnancy, while breastfeeding or by children; if you have diabetes or take any regular medicine, speak to your pharmacist or diabetes team before starting it, and never stop or replace a prescribed medicine on the strength of a supplement.